The miss breaks 4 quarters of beats, eroding the momentum narrative. Watch the William Blair conference (June 2) for any FY guidance color, a lower FY guide would compound the miss.
How the stock moved after the report
BEARISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 20 $209.14entry
- T+1 · 6mo ago −0.14%α −0.33% · $208.85
- T+5 · 6mo ago −2.83%α −4.63% · $203.22
- T+20 · 5mo ago −10.92%α −10.88% · $186.29
- T+60 · 3mo ago +7.33%α +2.59% · $224.46
Price Chart
How similar events traded
Executive Summary
Resmed reports fiscal Q3 2026 EPS of $2.86, a 1.4% miss vs consensus of $2.90. This is a modest negative relative to expectations for a med-tech bellwether, though absolute profit levels remain solid.
Key Financial Metrics
Key Facts
- EPS of $2.86 missed consensus estimate of $2.90 by $0.04 (1.4% miss)
- Street-convention EPS reversed a multi-quarter beat streak where prior 4 quarters beat consensus by 2.4-4.5%
- Revenue of $1.46B matched consensus (in-line, per provided context; no explicit beat/miss figure stated)
- No guidance change was provided; filing is an earnings miss without a mitigating guidance raise
Financial Impact
Miss of $0.04/share vs consensus; revenue in-line at $1.46B
Risk Factors
- EPS miss breaks positive surprise momentum, likely to pressure near-term valuation multiple
- No explicit guidance provided in this release; ambiguity around whether this was a one-quarter noise or a trend shift
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3297946 |
Track record
19 reports on RMD
3 of 4 bullish or bearish reports moved the stock their way by T+20. Best: +28.97% at T+60 after the Jun 1, 2026 report. 5 of 5 went positive at some point.
Filters
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $234.11 Now $238.19 +1.74% settles Dec 9
- Oct 29, 202618d ago 8-K Bullish 6/10 No price data
- Oct 29, 202618d ago Press Release Bullish 6/10 Entry $229.94 Now $238.19 +3.59% settles Nov 30
- Oct 16, 20264w ago Institutional Cluster Bearish 4/10 Entry $238.88 to $238.19 Now $238.19 +0.29% ▲ +0.29% −3.17% vs SPY
- Oct 7, 20265w ago 144 Neutral 3/10 Entry $226.73 to $240.51 Now $238.19 +5.05% ▲ +6.08% +11.37% vs SPY
- Oct 1, 20266w ago DEFA14A Neutral 2/10 Entry $218.89 to $229.94 Now $238.19 +8.82% ▲ +5.05% +6.86% vs SPY
- Oct 1, 20266w ago DEF 14A Neutral 4/10 Entry $218.89 to $252.83 Now $238.19 +8.82% ▲ +15.51% +17.31% vs SPY
- Oct 1, 20266w ago Press Release Neutral 1/10 Entry $218.89 Now $238.19 +8.82% No price data
- Sep 10, 20269w ago Insider Cluster Neutral 4/10 Entry $219.58 to $226.73 Now $238.19 +8.48% ▲ +3.26% +1.13% vs SPY
- Aug 11, 202613w ago Insider Cluster Neutral 2/10 Entry $224.84 to $219.95 Now $238.19 +5.94% ▼ −2.17% −1.12% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers